Latest & greatest articles for Ciclopirox

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Ciclopirox or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Ciclopirox and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Ciclopirox

1. Mycoster (ciclopirox) - seborrhoeic dermatitis of the scalp

Mycoster (ciclopirox) - seborrhoeic dermatitis of the scalp HAS - Medical, Economic and Public Health Assessment Division 1/23 The legally binding text is the original French version T TR RA AN NS SP PA AR RE EN NC CY Y C CO OM MM MI IT TT TE EE E Opinion 18 December 2013 MYCOSTER 10 mg/g, shampoo B/1 bottle of 60 ml (CIP: 34 009 368 640 0 9) Applicant: PIERRE FABRE DERMATOLOGIE INN ciclopirox ATC code (2012) D01AE14 (Antifungals for topical use) Reason for the request Inclusion Lists concerned (...) to the Marketing Authorisation: 30 October 2013 (replacement of parabens with sodium benzoate) Prescribing and dispensing conditions / special status Non-prescription medicine. ATC Classification 2012 D: Dermatologicals D01: Antifungals for dermatological use D01A: Antifungals for topical use D01AE: Other antifungals for topical use D01AE14: ciclopirox 02 BACKGROUND This is a request for inclusion of MYCOSTER 10 mg/g shampoo, which has had Marketing Authorisation for the treatment of seborrhoeic dermatitis

2014 Haute Autorite de sante

2. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States

Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States (...) Gupta A K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of ciclopirox 8% (continuous therapy), a novel topical lacquer, for the treatment of onychomycosis of the toe. Type of intervention Treatment. Economic study type

2000 NHS Economic Evaluation Database.